Kester doubles money on Chiltern sale

Kester sold its stake to existing investors, led by businessman Sir Douglas Myers and including management.

Kester, then Greenhill Capital Partners Europe, invested an undisclosed amount in the first round of funding for Chiltern via its GCPE Fund. The stake was acquired from one of the investors who backed a previous MBI in 2006.

Company
Founded in 1982, Chiltern is a clinical contract research organisation (CRO) that notably manages phase I-IV clinical trials across a range of therapeutic areas, and also provides functional service provision and contract staffing solutions. The business offers services in early-phase, global clinical development, late-phase, biometrics, medical and regulatory affairs as well as resourcing solutions.

Bath-based Chiltern employs more than 1,600 people globally and posted a £104m turnover in the year ending in March 2013 - up 17% on the previous year.

People
Adam Maidment led the deal for Kester Capital.

 

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• UK / Ireland
• Support services
• United Kingdom
• Kester Capital